Citizens Financial Group Inc. RI Buys 439 Shares of CME Group Inc. $CME

Citizens Financial Group Inc. RI increased its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 16.7% in the second quarter, Holdings Channel.com reports. The fund owned 3,064 shares of the financial services provider’s stock after purchasing an additional 439 shares during the period. Citizens Financial Group Inc. RI’s holdings in CME Group were worth $845,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Private Advisor Group LLC boosted its holdings in shares of CME Group by 3.6% during the 1st quarter. Private Advisor Group LLC now owns 7,251 shares of the financial services provider’s stock valued at $1,924,000 after purchasing an additional 251 shares during the last quarter. Kestra Private Wealth Services LLC increased its holdings in shares of CME Group by 7.4% in the first quarter. Kestra Private Wealth Services LLC now owns 5,088 shares of the financial services provider’s stock worth $1,350,000 after purchasing an additional 350 shares during the last quarter. OneAscent Financial Services LLC increased its holdings in shares of CME Group by 4.0% in the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock worth $293,000 after purchasing an additional 43 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its position in shares of CME Group by 4.4% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 27,851 shares of the financial services provider’s stock worth $7,389,000 after buying an additional 1,176 shares in the last quarter. Finally, Wealth Alliance LLC boosted its stake in CME Group by 4.1% during the first quarter. Wealth Alliance LLC now owns 1,484 shares of the financial services provider’s stock valued at $394,000 after buying an additional 58 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 0.1%

NASDAQ CME opened at $279.28 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $224.62 and a 52 week high of $290.79. The firm has a market capitalization of $100.71 billion, a price-to-earnings ratio of 27.06, a PEG ratio of 4.41 and a beta of 0.38. The company has a fifty day moving average of $268.02 and a two-hundred day moving average of $272.83.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the firm posted $2.68 earnings per share. The business’s revenue for the quarter was down 3.0% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s payout ratio is 48.45%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research reports. Piper Sandler lifted their price objective on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Jefferies Financial Group lowered their price objective on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research report on Friday, October 10th. Rothschild & Co Redburn boosted their target price on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a report on Thursday, November 6th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Finally, UBS Group reduced their price objective on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $287.65.

Get Our Latest Report on CME Group

Insider Buying and Selling at CME Group

In other news, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 14,043 shares of company stock valued at $3,791,486. 0.30% of the stock is owned by company insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.